Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults [Phase 1]
Phase 1 study assessing the absolute bioavailability, safety, and tolerability of subcutaneous GS-5745 in healthy adults. Ulcerative Colitis…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Disease Course in an IBD Cohort in the Era of Biological Treatment
This clinical trial update summarizes the disease course of an inflammatory bowel disease cohort (Crohn's disease and ulcerative colitis) in…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses [NA]
This terminated clinical trial evaluated a bioabsorbable staple line reinforcement device for colorectal, coloanal, and ileoanal anastomoses…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients [Phase 3]
A Phase 3 open-label trial of tacrolimus (FK506) in patients with refractory ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients [Phase 3]
A Phase 3 trial of tacrolimus (FK506) in moderate-to-severe refractory ulcerative colitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [NA]
A terminated pediatric trial assessed safety and compliance of once-daily mesalamine in children with Ulcerative Colitis; results are posted…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis [Phase 2]
Biogen completed a Phase 2 study of interferon beta-1a (Avonex) in active ulcerative colitis, with trial results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 2]
A placebo-controlled Phase 2 trial evaluated recombinant factor XIII (rFXIII) in adults with mild to moderate active ulcerative colitis; the…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis [Phase 3]
Phase 3 randomized, placebo-controlled trial of budesonide MMX 6 mg and 9 mg in ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis [Phase 3]
Phase 3 randomized, placebo-controlled trial of budesonide MMX 6 mg and 9 mg in ulcerative colitis completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial update for Vedolizumab in moderate to severe ulcerative colitis; the study completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease [Phase 2]
Phase 2 long-term safety results of vedolizumab (MLN0002) in patients with ulcerative colitis and Crohn's disease have been reported.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial of Vedolizumab given via multiple intravenous doses in patients with Ulcerative Colitis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab [Phase 4]
A Phase 4 clinical trial update evaluating Golimumab for ulcerative colitis, incorporating Physiological Intermolecular Modification Spectro…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D [NA]
This clinical trial update notes the completion of a study evaluating supplementation with Vitamin D3 (cholecalciferol) in patients with inf…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Efficacy of Infliximab as a Rescue Therapy in Pediatric Acute Severe Colitis
This completed trial evaluates infliximab as a rescue therapy for children with acute severe colitis. The update reports on the efficacy out…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets [Phase 3]
Phase 3 trial results for oral budesonide-MMX 9mg extended-release tablets in ulcerative colitis have been completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
This completed clinical trial analyzed advanced metagenomic profiles of the human colonic microbiota in patients with chronic GI disorders a…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness [NA]
A completed clinical study examining neuropsychiatric symptoms in pediatric inflammatory bowel disease and related depression.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis [Phase 2]
Phase 2 study evaluating efficacy, pharmacodynamics, safety and tolerability of oral BL-7040 in moderately active ulcerative colitis. Result…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of GLPG0974 in adults with Ulcerative Colit…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Ulcerative Colitis Relapse Prevention Trial, Hypnosis [NA]
A completed clinical trial from Northwestern University evaluated hypnosis as a relapse-prevention strategy for ulcerative colitis and infla…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating an oral anti-TNF antibody in patients with active ulcerative col…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]
The document reports on a phase 2/3 clinical trial of golimumab for moderately to severely active ulcerative colitis, presenting efficacy an…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Exacerbating Factors in Inflammatory Bowel Disease
The document provides an update on a completed clinical trial examining factors that exacerbate inflammatory bowel disease, including ulcera…